Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +33.64%
#3 Cysic Cysic +15.00%
#4 Fabric Protocol Fabric Protocol +9.87%
#5 Perle Perle +8.90%
#6 Bedrock Bedrock +8.53%
#7 The Black Bull The Black Bull +3.95%
#8 Centrifuge Centrifuge +3.80%
#9 Cap Cap +3.80%
#10 BOOK OF MEME BOOK OF MEME +3.69%
Coin of the day
EXOD EXOD
Setări
Limbă
ROMâNă
Monedă
USD
Temă
BerGenBio ASA BerGenBio ASA

BerGenBio ASA

BGBIO
Rang în acțiuni #37880
BerGenBio ASA is a biopharmaceutical firm in the clinical development stage,... BerGenBio ASA is a biopharmaceutical firm in the clinical development stage, focused on developing therapies for drug-resistant, immune-evasive, and metastatic cancers, in addition to respiratory conditions. Its leading compound, Bemcentinib, is a bio-available small molecule AXL inhibitor currently in Phase II clinical trials for major cancer indications and COVID-19. The Phase II trial program specifically addresses non-small cell lung cancer, acute myeloid leukemia, myelodysplastic syndrome, and COVID-19. Moreover, the company is progressing tilvestamab, an anti-AXL antibody, through Phase Ib clinical trials. BerGenBio ASA also maintains a collaboration agreement with Merck & Co. for its clinical studies. The company was founded in 2007 and operates from its base in Bergen, Norway.
Preț acțiune
$0.051239
Ultima sincronizare: 2025-11-24
Capitalizare de piață
$1.38M
Schimbare (1 zi)
-4.48%
Schimbare (1 an)
-54.57%
Țară
NO
Tranzacționează BerGenBio ASA (BGBIO)

Categorie

Healthcare
Istoric al prețului acțiunii pentru BerGenBio ASA (BGBIO)
Cel mai mare preț de închidere: $0.08 pe 2025-11-01

Cel mai mic preț de închidere: $45.81 pe 2017-04-01
Istoric al prețului acțiunii pentru BerGenBio ASA din 2017 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 36.04%
2025 -90.51%
2024 -63.90%
2023 -73.76%
2022 -63.83%
2021 -44.23%
2020 73.06%
2019 -30.98%
2018 -3.30%
2017 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE